46 unchanged sentences
Incorporation by Reference
−Removed: Sales Agreement by and between Registrant and Cowen and Company, LLC, dated January 5, 2024
+Added: Sales Agreement by and between Registrant and TD Securities (USA) LLC, dated January 6, 2025.
Amended and Restated Certificate of Incorporation.
2 unchanged sentences
Description of Capital Stock.
+Added: Form of Pre-Funded and Exchange
+Added: Form of Exchange Warrant
Olema Pharmaceuticals, Inc.
4 unchanged sentences
2020 Equity Incentive Plan.
+Added: Incorporation by Reference
Forms of Stock Option Grant Notice and Stock Option Agreement under the Olema Pharmaceuticals, Inc.
2020 Equity Incentive Plan.
−Removed: Incorporation by Reference
Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Olema Pharmaceuticals, Inc.
12 unchanged sentences
Olema Pharmaceuticals, Inc.
−Removed: 2022 Inducement Plan .
−Removed: Form of Stock Option Agreement and Option Grant Notice under the Inducement Plan.
+Added: 2022 Inducement Plan, as amended December 5, 2024.
Incorporation by Reference
+Added: Form of Stock Option Agreement and Option Grant Notice under the Inducement Plan.
Offer Letter by and between the Registrant and Naseem Zojwalla, dated December 15, 2021.
Drug Discovery Collaboration and License Agreement by and between the Registrant and Aurigene Discovery Technologies Limited, dated June 7, 2022.
−Removed: Separation Agreement by and between the Registrant and Cyrus Harmon, dated March 21, 2023.
−Removed: Separation Agreement by and between the Registrant and Kinney Horn, dated March 8, 2023.
+Added: Offer Letter by and between the Registrant and Shawnte Mitchell, dated January 27, 2025
Stock Purchase Agreement by and among the Registrant and the Purchasers named therein, dated September 5, 2023 .
Loan and Security Agreement by and between the Registrant and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, dated September 5, 2023 .
−Removed: Subsidiaries of the Registrant as of December 31, 2023.
+Added: Amendment No.
+Added: 2 to Amended and
+Added: Restated Clinical Collaboration and
+Added: Supply Agreement by and between
+Added: the Registrant and Novartis Institutes
+Added: for BioMedical Research, Inc., dated
+Added: March 22, 2024.
+Added: First Amendment to Loan and
+Added: Security Agreement by and between
+Added: the Registrant and Silicon Valley Bank, a division of First-Citizens Bank
+Added: & Trust Company, dated June 28,
+Added: Olema Pharmaceuticals, Inc.
+Added: Amended and Restated
+Added: Non-Employee Director
+Added: Compensation Policy.
+Added: Incorporation by Reference
+Added: Form of Securities Purchase
+Added: Agreement by and among the
+Added: Registrant and the Purchasers named
+Added: therein, dated November 29, 2024.
+Added: Clinical Trial Collaboration and Supply
+Added: Agreement by and between the
+Added: Registrant and Novartis Pharma AG,
+Added: dated November 29, 2024.
+Added: Amendment Number No.
+Added: 1 to the Drug Discovery Collaboration and License Agreement by and between the Registrant and Aurigene Oncology Limited, dated May 2, 2024
+Added: Amendment Number No.
+Added: 2 to the Drug Discovery Collaboration and License Agreement by and between the Registrant and Aurigene Oncology Limited, dated November 15, 2024
+Added: Olema Pharmaceuticals, Inc.
+Added: Insider Trading Policy
+Added: Subsidiaries of the Registrant.
Consent of Independent Registered Public Accounting Firm.
1 unchanged sentence
Certification of Principal Executive Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Incorporation by Reference
Certification of Principal Financial Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: Incorporation by Reference
Certification of Principal Executive Officer Pursuant to 18 U.S.C.
3 unchanged sentences
Incentive Compensation Recoupment Policy.
−Removed: XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL Document
−Removed: XBRL Taxonomy Extension Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
−Removed: XBRL Taxonomy Extension Label Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
+Added: Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL Document
+Added: Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
+Added: Cover Page formatted as Inline XBRL and contained in Exhibit 101
# Indicates management contract or compensatory plan or arrangement.
14 unchanged sentences
POWER OF ATTORNEY
−Removed: KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Sean Bohen, M.D., Ph.D.
−Removed: and Shane Kovacs, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution for him or her, and in his or her name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10‑K, and to file the same, with exhibits thereto and other documents in connection therewith, with the U.S.
+Added: KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Sean Bohen, M.D., Ph.D., Shane Kovacs and Shawnte Mitchell, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution for him or her, and in his or her name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10‑K, and to file the same, with exhibits thereto and other documents in connection therewith, with the U.S.
Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and either of them, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
8 unchanged sentences
March 18, 2025
−Removed: ( Principal Financial and Accounting Officer )
+Added: ( Principal Financial Officer and Principal Accounting Officer )
/s/ Ian Clark
23 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.